Recombitek Flu Single Dose Vaccination: Eq Influenza Vaccine

Recombinant equine influenza vaccine for immunization of horses against equine influenza virus (H3N8); canarypox-vectored or inactivated formulation. Recombinant canarypox vector equine influenza vaccine (Recombitek Equine Flu, Boehringer Ingelheim). Mechanism: recombinant canarypox virus vector expressing equine influenza HA protein → stimulates both humoral (neutralizing antibody) and cell-mediated immune responses without natural infection risk. Faster protective immunity, longer duration than killed vaccines. Key information Equine influenza vaccine (recombinant). Refrigerate; do not freeze. Shake well. Allow to reach room temperature. Record lot number. Do not vaccinate within 3 days of performance.

SQ or IM injection (per label): administer at appropriate site. Shake well before each use. before use. Have epinephrine available. Store refrigerated (2–8°C); do not freeze. If a dose is missed Contact your veterinarian to reschedule the missed vaccination. Timing of boosters is important for proper immune response.

Mild injection site reactions (swelling — 1–3 days). Low-grade fever, lethargy (vaccine reaction). Anaphylaxis (rare — observe 30 min post-vaccination). Generally well tolerated.

For animals Administer as directed. Monitor for anaphylaxis 30 min post-vaccination. Have epinephrine available. For people handling this medication Wash hands thoroughly with soap and water after handling. Avoid contact with eyes; if contact occurs, flush with water for 15 minutes and seek medical attention. Keep out of reach of children. If accidental ingestion occurs, contact Poison Control (1-800-222-1222). Equine vaccine — administered by veterinary staff. Wash hands thoroughly with soap and water after handling.

Contact your veterinarian. Vaccine overdose may cause local injection site reactions and transient fever. Rarely causes serious systemic effects.